SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans
6 references·2 citing·30 second hop
Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans (2003)Economic Consequences of Underuse of Gene…Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Outcomes of Reference Pricing…Users' Guides to the Medical Literature (1999)Users' Guides to the Medical …The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)The Importance of the Physici…Drug patent expirations and the speed of generic entry. (1997)Drug patent expirations and t…A physician survey on generic drugs and substitution of critical dose medications (1997)A physician survey on generic…A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications (1997)A Physician Survey on Generic…Sources of Regional Variation in Medicare Part D Drug Spending (2012)Sources of Regional Variation…Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid Spending (2006)Extensions Of Intellectual Pr…The political economy of the pharmaceutical industry. (1986)Entry and the Number of Firms in the Swedish Pharmaceuticals Market (2001)Estimating Nonresponse Bias in Mail Surveys (1977)What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice (2007)Generic medicines: Greek physicians’ perceptions and prescribing practices (2009)Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (2015)Payment Restrictions for Prescription Drugs under Medicaid (1987)METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Proposal of the Physicians' Working Group for Single-Payer National Health Insurance (2003)Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid (2004)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)On the Pooling of Time Series and Cross Section Data (1978)Designing Economic Agents that Act Like Human Agents: A Behavioral Approach to Bounded Rationality (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry (2000)Competition, Innovation and Productivity Growth: A Review of Theory and Evidence (2002)The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending (2003)Generic Drug Industry Dynamics (2005)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials (1997)Users' Guides to the Medical Literature (1999)Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers (2010)Network Meta-Analysis (2020)Male-Female Wage Differentials in Urban Labor Markets (1973)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)Social Determinants of Health and Geographic Variation in Medicare per Beneficiary Spending (2021)Exploring Generic Drug Use Behavior (2002)
this work references cited by second hop

References

  • 1998The Importance of the Physician in the Generic versus Trade-Name Prescription Decision300 cited
  • 2002Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors178 cited
  • 1999Users' Guides to the Medical Literature177 cited
  • 1997A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications104 cited
  • 1997A physician survey on generic drugs and substitution of critical dose medications100 cited
  • 1997Drug patent expirations and the speed of generic entry.73 cited

Cited by

  • 2012Sources of Regional Variation in Medicare Part D Drug Spending72 cited
  • 2006Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid Spending58 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work